Mankind Pharma
Mankind Pharma Limited, headquartered in New Delhi, India, is a prominent pharmaceutical company established in 1986 that focuses on the formulation, development, commercialization, and delivery of a wide array of pharmaceutical products. The company offers a diverse portfolio that includes antibiotics, antifungals, non-steroidal anti-inflammatory drugs (NSAIDs), gastrointestinal treatments, cardiovascular medications, and contraceptives, alongside over-the-counter medicines and nutritional supplements. Mankind Pharma also provides active pharmaceutical ingredients across various therapeutic areas such as cardiology, neurology, and gynecology. With a workforce exceeding 14,000, the company has built a strong presence in both the pharmaceutical and consumer healthcare sectors, catering primarily to the Indian market while also extending its reach to regions in Asia, Africa, Latin America, and the Gulf countries. Mankind Pharma is recognized for its well-established brands, including Manforce, Prega News, and Gas-O-Fast, and is committed to delivering affordable healthcare solutions to meet urgent medical needs.
12 past transactions
Innov8 Coworking
Venture Round in 2025
Innov8 Coworking is a Y-Combinator backed startup based in India that offers premium workspaces, including managed private offices and coworking spaces. As the first of its kind in India, Innov8 Coworking creates a productive environment that fosters community engagement among diverse individuals such as founders, investors, freelancers, and creators. The company currently operates multiple centers across major cities in India, including Delhi, Noida, Gurgaon, Mumbai, Bangalore, and Chandigarh. Innov8 Coworking provides essential amenities such as high-speed internet, meeting and conference rooms, and complimentary beverages, all aimed at facilitating collaboration and idea sharing among startup businesses.
Bharat Serums and Vaccines
Acquisition in 2024
Bharat Serums and Vaccines Limited is a biopharmaceutical company based in Thane, India, established in 1971. The company specializes in researching, developing, manufacturing, and marketing a wide range of injectable biological and pharmaceutical products. Its diverse portfolio includes plasma derivatives, monoclonal antibodies, fertility hormones, antifungals, anesthetics, cardiovascular drugs, and equine immunoglobulins. Bharat Serums and Vaccines also focuses on advanced research and development in drug delivery systems, biotechnology therapeutics, and therapeutic proteins. It serves various medical fields such as gynecology, critical care, emergency medicine, neurology, nephrology, hematology, and urology. The company distributes its products primarily within India and extends its reach to international markets, including the Asia Pacific, Latin America, and Africa. Bharat Serums and Vaccines operates manufacturing facilities in India and Germany, along with research and development facilities in India, Germany, and the United States.
Actimed Therapeutics
Series A in 2023
Actimed Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative treatments for muscle wasting disorders. Established in 2017, the company specializes in creating anabolic/catabolic transforming agents to manage cachexia, a severe syndrome linked with various chronic illnesses, particularly cancer-related cachexia.
Actimed Therapeutics
Series A in 2023
Actimed Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative treatments for muscle wasting disorders. Established in 2017, the company specializes in creating anabolic/catabolic transforming agents to manage cachexia, a severe syndrome linked with various chronic illnesses, particularly cancer-related cachexia.
Actimed Therapeutics
Seed Round in 2023
Actimed Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative treatments for muscle wasting disorders. Established in 2017, the company specializes in creating anabolic/catabolic transforming agents to manage cachexia, a severe syndrome linked with various chronic illnesses, particularly cancer-related cachexia.
Upakarma Ayurveda
Acquisition in 2022
Upakarma Ayurveda is a prominent Ayurvedic brand in India, recognized for its rapid growth and commitment to delivering high-quality health and wellness products. The company specializes in a diverse range of offerings, including shilajit, kesar, juices, and various immunity boosters. Upakarma Ayurveda also provides skin and health care solutions available in capsules and drops, aiming to promote a balanced and healthy lifestyle for its customers. Through its focus on premium Ayurvedic formulations, the brand seeks to enhance overall well-being while adhering to traditional practices.
BatX Energies
Seed Round in 2022
BatX Energies operates a platform for recycling lithium-ion batteries. It offers comprehensive services from collection and transportation of spent batteries to extraction of essential metals, creating battery-grade materials. This facilitates a circular economy, reducing environmental impact and supporting sustainable energy transition.
Bellatrix Aerospace
Series A in 2022
Bellatrix Aerospace is an Indian space research and development company focused on advanced technologies for in-space mobility and satellite propulsion. The company specializes in eco-friendly orbital launch vehicles and systems designed for the navigation of heavy, micro, and nanosatellites. By developing innovative propulsion technologies, Bellatrix Aerospace aims to enhance in-orbit satellite navigation and provide essential tools for deep space exploration. Its commitment to sustainable practices positions the company as a key player in the aerospace industry, facilitating access to space navigation capabilities for various stakeholders.
Leverage Edu
Series B in 2022
Leverage Edu is an AI-driven platform facilitating students' higher education and career growth. It democratizes mentorship, breaking traditional barriers to help students worldwide secure admission to suitable programs.
Panacea Biotec Pharma - Formulations business
Acquisition in 2022
Panacea Biotec Pharma - Formulations business offers pharma formulations.
Dogsee Chew
Series A in 2022
Dogsee Chew is formed for the love of dogs. Bhupendra wanted to bring organic foods for dogs - a healthy treat with high protein and less carbs, and he ended up with Dogsee Chew. It is a highly nutritious high quality snacking option for your dogs.
Miko
Series B in 2021
Miko is a consumer electronics company developing an artificial intelligence-based companion robot to educate and entertain children. Its platform specializes in offering a personalized learning experience and educational journey for every child where the companion robot adapts to its user's communication styles and features a parental dashboard to control the content of interactions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.